Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XBB.1.5.93NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.2.3.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.4.8NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EG.5.1.18NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HK.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GM.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.13.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GV.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EG.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.25NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BN.1.2.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.16.26NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GJ.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EG.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CM.12NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
DY.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.7.14.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.3.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
DY.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HH.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EM.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FD.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GF.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EG.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.24NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FU.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.4.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GY.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.1.18NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.3.1 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.1.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.1.15.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.1.15.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.36 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.1.1.18NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.1.1.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.1.1.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.1.1.14NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.1.20NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.43.4 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.57 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.1.17NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.1.1.8NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.1.1.10NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.1.9NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.3.3 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.28.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EG.5.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used